Arlocabtagene autoleucel

DB24024InvestigationalCell transplant therapies

Arlocabtagene Autoleucel is a biologic drug. Arlocabtagene Autoleucel is under investigation in clinical trial NCT06297226 (Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With...

Mechanism: Pharmacologically active on G protein-coupled receptor family C group 5 member D
Curator reviewed
Also known as: Arlo-cel
Code names: BMS-986393 · CC-95266

Resolves to

Compound

UNIIWQ79GLJ8VP

Targets

Q9NZD1GPRC5D

What you can answer from here — as of June 28, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Arlocabtagene autoleucel, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account